Targeting the source.
Transforming the outcome.

We develop miRNA-based therapies that address the root causes of neurological diseases. This goes far beyond the limitations of current treatment options, which only manage individual symptoms.

Read more

A future where patients with neurological diseases are effectively treated

We are committed to unlocking the full potential of miRNA therapy as a new frontier in the treatment of neurological diseases. With diligence and creativity, we advance promising therapies that harness the power of miRNA biology to effectively treat diseases such as Epilepsy and Parkinson’s.

Building on this commitment, we engage with patients, caregivers and the medical community to ensure we’re working towards outcomes that are truly life changing.

Our Science
Our miRNA-targeting approach restores balance by guiding neural networks back to healthy function.
Read more
For Patients
Conventional medicine for neurological disease has limitations. By correcting the root causes of disease, our miRNA therapies remedy its diverse impacts for improved patient outcomes.
Read more

We share our latest development updates, scientific publications and industry perspectives

11.6.2025
Neumirna Receives 2025 Epilepsy Foundation Shark Tank Investment
$200,000 award supports Neumirna’s RNA-based approach to innovation in epilepsy treatment
Read more
8.5.2025
Neumirna Strengthens Board with Andreas Wallnöfer as Independent Board Member
Neumirna Therapeutics has named Andreas Wallnöfer as an independent member of its Board of Directors.
Read more
1.5.2025
Lina's Story: In Honor of World Parkinson's Day
"When the doctor told me she suspected it might be Parkinson's, I responded, 'That can't be right. I don’t even tremble." Today, on World Parkinson’s Day, we’re honored to share Lina’s story – an intimate and honest glimpse into the daily reality of living with this complex condition.
Read more
See all news

Investors

Work with us

Interested in joining Neumirna? Explore current career opportunities or contact us to learn how you can contribute to our mission.

Learn more